Special Dosing Considerations
is a topic covered in the Davis's Drug Guide
To view the entire topic, please sign in or purchase a subscription.
The Washington Manual of Medical Therapeutics helps you diagnose and treat hundreds of medical conditions. Consult clinical recommendations from a resource that has been trusted on the wards for 50+ years. Explore these free sample topics:
-- The first section of this topic is shown below --
For many patients the average dose range for a given drug can be toxic. The purpose of this section is to describe vulnerable patient populations for which special dosing considerations must be made to protect the patient and improve clinical outcomes.
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Quiring, Courtney, et al. "Special Dosing Considerations." Davis's Drug Guide, 16th ed., F.A. Davis Company, 2019. Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations.
Quiring C, Sanoski CA, Vallerand AH. Special Dosing Considerations. Davis's Drug Guide. 16th ed. F.A. Davis Company; 2019. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations. Accessed October 22, 2019.
Quiring, C., Sanoski, C. A., & Vallerand, A. H. (2019). Special Dosing Considerations. In Davis's Drug Guide. Available from https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations
Quiring C, Sanoski CA, Vallerand AH. Special Dosing Considerations [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2019. [cited 2019 October 22]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations.
TY - ELEC
T1 - Special Dosing Considerations
ID - 109953
A1 - Quiring,Courtney,
AU - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations
PB - F.A. Davis Company
ET - 16
DB - Washington Manual
DP - Unbound Medicine